The largest database of trusted experimental protocols

4 protocols using gramicidin d

1

Antibacterial Evaluation of Oral Products

Check if the same lab product or an alternative is used in the 5 most similar protocols
The antibacterial properties of the products were assayed against S. mutans, A. naeslundii, and P. gingivalis. Each bacterium was procured from the American Type Culture Collection (Manassas, VA, USA) and frozen until further analysis. First, the frozen bacterial stocks were thawed and grown on brain heart infusion (BHI) medium (Pearlcore®, Eiken Chemical, Co., Ltd., Tokyo, Japan) supplemented with 0.1% antibiotic (0.05% gramicidin D and 0.05% bacitracin, FUJIFILM Wako Pure Chemical Corporation) and 1% sucrose (FUJIFILM Wako Pure Chemical Corporation).
In a 96-well plate, S. mutans (1.1 × 106 CFU/200 µL/well), A. naeslundii (1.0 × 106 CFU/200 µL/well), and P. gingivalis (2.8 × 109 CFU/200 µL/well) were incubated for 24 h at 37 °C under anaerobic conditions in the BHI medium supplemented with the product at various doses: 0 (ctrl), 0.001, 0.01, and 0.1 w/v%. After incubation, the metabolic activity of the bacteria (proportional to the number of living bacteria) was assayed using a microbial viability assay kit-WST (DOJINDO Laboratories, Mashiki, Japan) according to the manufacturer’s instructions, and the absorbance was measured at 450 nm using a microplate reader (Multiskan FC, Thermo Fisher Scientific, Waltham, MA, USA). The pH of each bacterial suspension was measured before and after incubation using a portable pH meter (LAQUA-PH-SE, HORIBA, Ltd., Kyoto, Japan).
+ Open protocol
+ Expand
2

Bacterial Cultivation Conditions

Check if the same lab product or an alternative is used in the 5 most similar protocols
Facultative anaerobic bacteria, S. mutans ATCC 35668 and A. actinomycetemcomitans ATCC 29522, and obligate anaerobic bacteria, P. gingivalis ATCC 33277, were kept frozen until analysis. The stocks were incubated in brain heart infusion (BHI) broth (Pearlcore®, Eiken Chemical Co. Ltd., Tokyo, Japan) supplemented with 0.1% antibiotic (gramicidin D and bacitracin, Wako Pure Chemical Industries Ltd.) and 1% sucrose for S. mutans; 1% yeast extract (Wako Pure Chemical Industries Ltd.) for A. actinomycetemcomitans; and 0.5% yeast extract, 0.0005% hemin, and 0.0001% menadione for P. gingivalis.
+ Open protocol
+ Expand
3

Bacterial Culturing for Oral Pathogens

Check if the same lab product or an alternative is used in the 5 most similar protocols
All chemicals were used as received without further purification. Glutathione (reduced form, 98% purity), methotrexate (MTX, 98.0% purity), methanol (99.7% purity), D2O (99.9% purity), and silver nitrate (99.9% purity) were purchased from FUJIFILM Wako Pure Chemical Corporation Ltd. (Osaka, Japan). Sodium borohydride (NaBH4, 99.99% purity) was purchased from Sigma-Aldrich (St. Louis, MO, USA).
Bacterial strains used in this study were S. mutans ATCC 35668, A. actinomycetemcomitans ATCC 29522, and P. gingivalis ATCC 33277. These strains were kept frozen until analysis. Bacterial stocks were anaerobically and statically incubated in brain heart infusion (BHI) broth (Pearlcore®, Eiken Chemical, Co., Ltd., Tokyo, Japan) supplemented with 0.1% antibiotics (gramicidin D and bacitracin, FUJIFILM Wako Pure Chemical Corporation Ltd.) and 1% sucrose (FUJIFILM Wako Pure Chemical Corporation Ltd.) for S. mutans; 1% yeast extract (FUJIFILM Wako Pure Chemical Corporation Ltd.) for A. actinomycetemcomitans; and 0.5% yeast extract, 0.0005% hemin, and 0.0001% menadione for P. gingivalis. Anaerobic incubation was carried out in an AnaeroPack system using anaerobic jars (Mitsubishi Gas Chemical Company, Inc., Tokyo, Japan).
+ Open protocol
+ Expand
4

Cultivation of Oral Bacterial Strains

Check if the same lab product or an alternative is used in the 5 most similar protocols
Strains of bacterial
cells, gram-positive facultative anaerobic bacteria (Streptococcus mutans ATCC 35668 and Actinomyces naeslundii ATCC 27039), gram-negative
facultative anaerobic bacteria (Escherichia coli ATCC 25922), and gram-negative obligate anaerobic bacteria (Porphyromonas gingivalis ATCC 63143627 and Prevotella intermedia ATCC 25611) were obtained from
the American Type Culture Collection (Manassas, VA, USA). The bacteria
were grown anaerobically using an Anaeropack system (Mitsubishi Gas
Chemical Company, Inc., Tokyo, Japan) and brain heart infusion broth
(Eiken Chemical, Co., Ltd., Tokyo, Japan) supplemented as follows:
no supplementation for E. coli; 1%
sucrose (FUJIFILM Wako Pure Chemical Corporation) and antibiotics;
0.1% gramicidin D and bacitracin (FUJIFILM Wako Pure Chemical Corporation)
for S. mutans; and 0.5% yeast extract,
0.0005% hemin (Sigma-Aldrich Co. LLC, St. Louis, MO, USA), and 0.0001%
menadione (Sigma-Aldrich Co. LLC) for P. gingivalis and P. intermedia. A. naeslundii was grown in Actinomyces broth (Becton
Dickinson and Company, Franklin Lakes, NJ, USA). For antibacterial
assessments, bacteria in log-phase growth were diluted to final concentrations
of approximately 1 × 107 colony-forming units (CFU)
per mL.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!